1. Home
  2. SNSE

SNSE

Sensei Biotherapeutics Inc.

Logo Sensei Biotherapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 9:50am EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

Founded: 2005 Country:
United States
United States
Employees: N/A City: ROCKVILLE
Market Cap: 26.3M IPO Year: 2021
Target Price: $4.00 AVG Volume (30 days): 66.9K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.22 EPS Growth: N/A
52 Week Low/High: $0.51 - $1.93 Next Earning Date: 05-07-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: